Annual Shareholders Equity
$433.43 M
+$92.83 M+27.25%
December 31, 2023
Summary
- As of February 7, 2025, AMLX annual stockholders equity is $433.43 million, with the most recent change of +$92.83 million (+27.25%) on December 31, 2023.
- During the last 3 years, AMLX annual shareholders equity has risen by +$500.16 million (+749.58%).
- AMLX annual shareholders equity is now at all-time high.
Performance
AMLX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$196.20 M
-$65.11 M-24.92%
September 30, 2024
Summary
- As of February 7, 2025, AMLX quarterly stockholders equity is $196.20 million, with the most recent change of -$65.11 million (-24.92%) on September 30, 2024.
- Over the past year, AMLX quarterly shareholders equity has dropped by -$222.20 million (-53.11%).
- AMLX quarterly shareholders equity is now -54.73% below its all-time high of $433.43 million, reached on December 31, 2023.
Performance
AMLX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
AMLX Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +27.3% | -53.1% |
| 3 y3 years | +749.6% | -53.1% |
| 5 y5 years | +1809.3% | -53.1% |
AMLX Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +386.7% | -54.7% | +229.8% |
| 5 y | 5-year | at high | +386.7% | -54.7% | +229.8% |
| alltime | all time | at high | +386.7% | -54.7% | +229.8% |
Amylyx Pharmaceuticals Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $196.20 M(-24.9%) |
| Jun 2024 | - | $261.31 M(-19.5%) |
| Mar 2024 | - | $324.44 M(-25.1%) |
| Dec 2023 | $433.43 M(+27.3%) | $433.43 M(+3.6%) |
| Sep 2023 | - | $418.40 M(+8.3%) |
| Jun 2023 | - | $386.37 M(+9.6%) |
| Mar 2023 | - | $352.65 M(+3.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $340.61 M(-325.3%) | $340.61 M(+136.5%) |
| Sep 2022 | - | $144.03 M(-25.3%) |
| Jun 2022 | - | $192.79 M(-20.0%) |
| Mar 2022 | - | $240.95 M(-259.4%) |
| Dec 2021 | -$151.17 M(+126.6%) | -$151.17 M(+21.8%) |
| Sep 2021 | - | -$124.07 M(+85.9%) |
| Dec 2020 | -$66.72 M(+163.1%) | -$66.72 M |
| Dec 2019 | -$25.36 M | - |
FAQ
- What is Amylyx Pharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for Amylyx Pharmaceuticals?
- What is Amylyx Pharmaceuticals annual shareholders equity year-on-year change?
- What is Amylyx Pharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Amylyx Pharmaceuticals?
- What is Amylyx Pharmaceuticals quarterly shareholders equity year-on-year change?
What is Amylyx Pharmaceuticals annual stockholders equity?
The current annual shareholders equity of AMLX is $433.43 M
What is the all time high annual shareholders equity for Amylyx Pharmaceuticals?
Amylyx Pharmaceuticals all-time high annual stockholders equity is $433.43 M
What is Amylyx Pharmaceuticals annual shareholders equity year-on-year change?
Over the past year, AMLX annual stockholders equity has changed by +$92.83 M (+27.25%)
What is Amylyx Pharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of AMLX is $196.20 M
What is the all time high quarterly shareholders equity for Amylyx Pharmaceuticals?
Amylyx Pharmaceuticals all-time high quarterly stockholders equity is $433.43 M
What is Amylyx Pharmaceuticals quarterly shareholders equity year-on-year change?
Over the past year, AMLX quarterly stockholders equity has changed by -$222.20 M (-53.11%)